Solid Biosciences Inc.

NasdaqGS:SLDB Stock Report

Market Cap: US$997.2m

Solid Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:SLDB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Jun 26BuyUS$22,142,224RA Capital Management, L.P.Company2,696,148US$8.30
17 Mar 26BuyUS$23,710,166RA Capital Management, L.P.Company3,155,031US$7.79
06 Feb 26BuyUS$2,303,535RA Capital Management, L.P.Company354,936US$6.49
04 Feb 26SellUS$315,093Alexander CumboIndividual48,913US$6.44
04 Feb 26SellUS$121,713David HowtonIndividual18,894US$6.44
04 Feb 26SellUS$70,249Paul HerzichIndividual10,905US$6.44
04 Feb 26SellUS$79,545Jessie HanrahanIndividual12,348US$6.44
04 Feb 26SellUS$81,271Gabriel BrooksIndividual12,616US$6.44
04 Feb 26SellUS$95,231Kevin TanIndividual14,783US$6.44
04 Feb 26SellUS$46,414Ilan GanotIndividual7,205US$6.44
10 Nov 25SellUS$13,505Ilan GanotIndividual3,278US$4.12

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SLDB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders971,3300.83%
VC/PE Firms41,441,99635.4%
Institutions74,622,51963.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 37.7%.

Top Shareholders

Top 25 shareholders own 96.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.2%
RA Capital Management, L.P.
12,036,126US$111.9m28.9%0.94%
11.1%
Perceptive Advisors LLC
11,906,646US$110.7m0%1.65%
9.15%
Bain Capital Life Sciences Investors, LLC
9,808,819US$91.2m0%5.57%
7.17%
Artal Group S.A.
7,690,405US$71.5m0%1.05%
6.47%
BlackRock, Inc.
6,934,248US$64.5m39.9%no data
6.41%
FMR LLC
6,875,845US$63.9m90.7%no data
4.2%
Vanguard Capital Management, LLC
4,504,652US$41.9m50.1%no data
3.99%
Armistice Capital LLC
4,278,000US$39.8m33.7%1.0%
3.89%
State Street Investment Management
4,175,365US$38.8m271%no data
3.77%
Janus Henderson Group Ltd.
4,043,605US$37.6m0.82%0.01%
3.63%
RTW Investments, LP
3,892,926US$36.2m0%0.3%
3.32%
Deep Track Capital, LP
3,565,062US$33.2m0%0.45%
3.21%
Franklin Templeton Inc.
3,440,401US$32.0m56.9%0.01%
2.63%
Citadel Advisors LLC
2,815,122US$26.2m8.41%0.02%
2.13%
Alyeska Investment Group, L.P.
2,280,484US$21.2m0.02%0.06%
2.08%
Columbia Management Investment Advisers, LLC
2,225,783US$20.7m-8.74%no data
2.01%
Vestal Point Capital, LP
2,160,000US$20.1m-56.8%0.47%
1.82%
Redmile Group, LLC
1,948,695US$18.1m-3.14%1.04%
1.81%
Geode Capital Management, LLC
1,940,824US$18.0m49.8%no data
1.4%
Adage Capital Management, L.P.
1,506,506US$14.0m-14.2%0.02%
1.32%
The Goldman Sachs Group, Inc.
1,412,094US$13.1m62.2%no data
1.18%
Dimensional Fund Advisors LP
1,266,290US$11.8m32.4%no data
0.85%
Invus Financial Advisors, LLC
913,365US$8.5m0%4.06%
0.71%
William Blair Investment Management, LLC
756,277US$7.0m16.1%0.01%
0.7%
Vanguard Portfolio Management, LLC
748,589US$7.0m121%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/23 05:03
End of Day Share Price 2026/08/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Solid Biosciences Inc. is covered by 23 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Timothy ChiangBTIG
Kristen KluskaCantor Fitzgerald & Co.
Charles DuncanCantor Fitzgerald & Co.